Nkarta Therapeutics
IPONkarta Inc. | Natural Killer Cell Therapy Autoimmune Care
Public · South San Francisco, United States · Founded 2015 · $114.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- nkartatx.com
- Total Funding
- $114.0M
- Last Round
- $114.0M Series BSep 2019
- Rounds
- 3
- Type
- Public
About
Nkarta is a clinical-stage biotechnology company advancing allogeneic, off-the-shelf natural killer (NK) cell therapies to treat autoimmune disease. Combining cell expansion and cryopreservation platforms with proprietary engineering technologies, Nkarta's lead candidate NKX019 uses donor-derived NK cells to target B cell-mediated autoimmune conditions including lupus, enabling outpatient community health setting dosing.
Summary
Nkarta Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2015. It has raised $114.0M in total across 3 rounds, most recently a $114.0M Series B round in Sep 2019. Investors include Samsara BioCapital, NEA and SR One.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Mar 2024
Sign up to see all 5 rounds
Seed through Secondary Market — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nkarta-therapeutics"><img src="https://indexed.vc/api/badge/company/nkarta-therapeutics" alt="Nkarta Therapeutics on Indexed.vc" width="260" height="76" /></a>